[1]
|
(2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1204-1222.
|
[2]
|
Cuevas-Ramos, G., Petit, C.R., Marcq, I., et al. (2010) Escherichia coli Induces DNA Damage in Vivo and Triggers Genomic Instability in Mammalian Cells. Proceedings of the National Academy of Sciences of the United States of America, 107, 11537-11542. https://doi.org/10.1073/pnas.1001261107
|
[3]
|
He, Z., Gharaibeh, R.Z., Newsome, R.C., et al. (2019) Campylobacter jejuni Promotes Colorectal Tumorigenesis through the Action of Cytolethal Distending Toxin. Gut, 68, 289-300. https://doi.org/10.1136/gutjnl-2018-317200
|
[4]
|
Maddocks, O.D., Scanlon, K.M. and Donnenberg, M.S. (2013) An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins. mBio, 4, e00152-13. https://doi.org/10.1128/mBio.00152-13
|
[5]
|
Santos, J.C., Brianti, M.T., Almeida, V.R., et al. (2017) Helicobacter pylori Infection Modulates the Expression of miRNAs Associated with DNA Mismatch Repair Pathway. Molecular Carcinogenesis, 56, 1372-1379. https://doi.org/10.1002/mc.22590
|
[6]
|
Lopès, A., Billard, E., Casse, A.H., et al. (2020) Colibactin-Positive Escherichia coli Induce a Procarcinogenic Immune Environment Leading to Immunotherapy Resistance in Colorectal Cancer. International Journal of Cancer, 146, 3147-3159. https://doi.org/10.1002/ijc.32920
|
[7]
|
Ling, Z., Shao, L., Liu, X., et al. (2019) Regulatory T Cells and Plasmacytoid Dendritic Cells within the Tumor Microenvironment in Gastric Cancer Are Correlated with Gastric Microbiota Dysbiosis: A Preliminary Study. Frontiers in Immunology, 10, Article 533. https://doi.org/10.3389/fimmu.2019.00533
|
[8]
|
Chung, L., Orberg, E.T., Geis, A.L., et al. (2018) Bacteroides fragilis Toxin Coordinates a Pro-Carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host & Microbe, 23, 421. https://doi.org/10.1016/j.chom.2018.02.004
|
[9]
|
Lee, J.A., Yoo, S.Y., Oh, H.J., et al. (2021) Differential Immune Microenvironmental Features of Microsatellite-Unstable Colorectal Cancers According to Fusobacterium nucleatum Status. Cancer Immunology, Immunotherapy, 70, 47-59. https://doi.org/10.1007/s00262-020-02657-x
|
[10]
|
Wang, F., Meng, W., Wang, B., et al. (2014) Helicobacter pylori-Induced Gastric Inflammation and Gastric Cancer. Cancer Letters, 345, 196-202. https://doi.org/10.1016/j.canlet.2013.08.016
|
[11]
|
Nguyen, T.T., Lian, S., Ung, T.T., et al. (2017) Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity. Journal of Cellular Biochemistry, 118, 2958-2967. https://doi.org/10.1002/jcb.25955
|
[12]
|
Flynn, C., Montrose, D.C., Swank, D.L., et al. (2007) Deoxycholic Acid Promotes the Growth of Colonic Aberrant Crypt Foci. Molecular Carcinogenesis, 46, 60-70. https://doi.org/10.1002/mc.20253
|
[13]
|
Rossi, T., Vergara, D., Fanini, F., et al. (2020) Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International Journal of Molecular Sciences, 21, Article 5786. https://doi.org/10.3390/ijms21165786
|
[14]
|
Maisonneuve, C., Tsang, D.K.L., Foerster, E.G., et al. (2021) Nod1 Promotes Colorectal Carcinogenesis by Regulating the Immunosuppressive Functions of Tumor-Infiltrating Myeloid Cells. Cell Reports, 34, Article ID: 108677. https://doi.org/10.1016/j.celrep.2020.108677
|
[15]
|
Kim, J.H., Kordahi, M.C., Chac, D., et al. (2020) Toll-Like Receptor-6 Signaling Prevents Inflammation and Impacts Composition of the Microbiota during Inflammation-Induced Colorectal Cancer. Cancer Prevention Research (Phila), 13, 25-40. https://doi.org/10.1158/1940-6207.CAPR-19-0286
|
[16]
|
Overacre-Delgoffe, A.E., Bumgarner, H.J., Cillo, A.R., et al. (2021) Microbiota-Specific T Follicular Helper Cells Drive Tertiary Lymphoid Structures and Anti-Tumor Immunity against Colorectal Cancer. Immunity, 54, 2812-2824.e4. https://doi.org/10.1016/j.immuni.2021.11.003
|
[17]
|
Blaser, M.J. and Atherton, J.C. (2004) Helicobacter pylori Persistence: Biology and Disease. Journal of Clinical Investigation, 113, 321-333. https://doi.org/10.1172/JCI20925
|
[18]
|
Ohnishi, N., Yuasa, H., Tanaka, S., et al. (2008) Transgenic Expression of Helicobacter pylori CagA Induces Gastrointestinal and Hematopoietic Neoplasms in Mouse. Proceedings of the National Academy of Sciences of the United States of America, 105, 1003-1008. https://doi.org/10.1073/pnas.0711183105
|
[19]
|
Dicksved, J., Lindberg, M., Rosenquist, M., et al. (2009) Molecular Characterization of the Stomach Microbiota in Patients with Gastric Cancer and in Controls. Journal of Medical Microbiology, 58, 509-516. https://doi.org/10.1099/jmm.0.007302-0
|
[20]
|
Mowat, C., Williams, C., Gillen, D., et al. (2000) Omeprazole, Helicobacter pylori Status, and Alterations in the Intragastric Milieu Facilitating Bacterial N-Nitrosation. Gastroenterology, 119, 339-347. https://doi.org/10.1053/gast.2000.9367
|
[21]
|
Lertpiriyapong, K., Whary, M.T., Muthupalani, S., et al. (2014) Gastric Colonisation with a Restricted Commensal Microbiota Replicates the Promotion of Neoplastic Lesions by Diverse Intestinal Microbiota in the Helicobacter pylori INS-GAS Mouse Model of Gastric Carcinogenesis. Gut, 63, 54-63. https://doi.org/10.1136/gutjnl-2013-305178
|
[22]
|
Jo, H.J., Kim, J., Kim, N., et al. (2016) Analysis of Gastric Microbiota by Pyrosequencing: Minor Role of Bacteria Other than Helicobacter pylori in the Gastric Carcinogenesis. Helicobacter, 21, 364-374. https://doi.org/10.1111/hel.12293
|
[23]
|
Wang, L., Zhou, J., Xin, Y., et al. (2016) Bacterial Overgrowth and Diversification of Microbiota in Gastric Cancer. European Journal of Gastroenterology & Hepatology, 28, 261-266. https://doi.org/10.1097/MEG.0000000000000542
|
[24]
|
Schulz, C., Schutte, K., Koch, N., et al. (2018) The Active Bacterial Assemblages of the Upper GI Tract in Individuals with and without Helicobacter Infection. Gut, 67, 216-225. https://doi.org/10.1136/gutjnl-2016-312904
|
[25]
|
Coker, O.O., Dai, Z., Nie, Y., et al. (2018) Mucosal Microbiome Dysbiosis in Gastric Carcinogenesis. Gut, 67, 1024-1032. https://doi.org/10.1136/gutjnl-2017-314281
|
[26]
|
Sun, J.H., Li, X.L., Yin, J., et al. (2018) A Screening Method for Gastric Cancer by Oral Microbiome Detection. Oncology Reports, 39, 2217-2224. https://doi.org/10.3892/or.2018.6286
|
[27]
|
Eun, C.S., Kim, B.K., Han, D.S., et al. (2014) Differences in Gastric Mucosal Microbiota Profiling in Patients with Chronic Gastritis, Intestinal Metaplasia, and Gastric Cancer Using Pyrosequencing Methods. Helicobacter, 19, 407-416. https://doi.org/10.1111/hel.12145
|
[28]
|
Wong, B.C., Lam, S.K., Wong, W.M., et al. (2004) Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial. JAMA, 291, 187-194. https://doi.org/10.1001/jama.291.2.187
|
[29]
|
Weisburger, J.H., Reddy, B.S., Narisawa, T., et al. (1975) Germ-Free Status and Colon Tumor Induction by N-methyl-N’-nitro-N-nitrosoguanidine. Proceedings of the Society for Experimental Biology and Medicine, 148, 1119-1121. https://doi.org/10.3181/00379727-148-38700
|
[30]
|
Rezasoltani, S., Asadzadeh Aghdaei, H., Dabiri, H., et al. (2018) The Association between Fecal Microbiota and Different Types of Colorectal Polyp as Precursors of Colorectal Cancer. Microbial Pathogenesis, 124, 244-249. https://doi.org/10.1016/j.micpath.2018.08.035
|
[31]
|
Sze, M.A., Baxter, N.T., Ruffin, M.T.T., et al. (2017) Normalization of the Microbiota in Patients after Treatment for Colonic Lesions. Microbiome, 5, Article No. 150. https://doi.org/10.1186/s40168-017-0366-3
|
[32]
|
Alozie, A., Koller, K., Pose, L., et al. (2015) Streptococcus bovis Infectious Endocarditis and Occult Gastrointestinal Neoplasia: Experience with 25 Consecutive Patients Treated Surgically. Gut Pathogens, 7, Article No. 27. https://doi.org/10.1186/s13099-015-0074-0
|
[33]
|
Corredoira, J., Grau, I., Garcia-Rodriguez, J.F., et al. (2015) The Clinical Epidemiology and Malignancies Associated with Streptococcus bovis Biotypes in 506 Cases of Bloodstream Infections. Journal of Infection, 71, 317-325. https://doi.org/10.1016/j.jinf.2015.05.005
|
[34]
|
Geis, A.L., Fan, H., Wu, X., et al. (2015) Regulatory T-Cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis. Cancer Discovery, 5, 1098-1109. https://doi.org/10.1158/2159-8290.CD-15-0447
|
[35]
|
Tilg, H., Adolph, T.E., Gerner, R.R., et al. (2018) The Intestinal Microbiota in Colorectal Cancer. Cancer Cell, 33, 954-964. https://doi.org/10.1016/j.ccell.2018.03.004
|
[36]
|
Schmitt, M. and Greten, F.R. (2021) The Inflammatory Pathogenesis of Colorectal Cancer. Nature Reviews Immunology, 21, 653-667. https://doi.org/10.1038/s41577-021-00534-x
|
[37]
|
Keku, T.O., Mccoy, A.N. and Azcarate-Peril, A.M. (2013) Fusobacterium spp. and Colorectal Cancer: Cause or Consequence? Trends in Microbiology, 21, 506-508. https://doi.org/10.1016/j.tim.2013.08.004
|
[38]
|
Rubio, C.A. and Schmidt, P.T. (2018) Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer. Anticancer Research, 38, 3811-3815. https://doi.org/10.21873/anticanres.12664
|
[39]
|
Queen, J., Domingue, J.C., White, J.R., et al. (2021) Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models. mBio, 13, e0299121. https://doi.org/10.1128/mbio.02991-21
|
[40]
|
Gur, C., Ibrahim, Y., Isaacson, B., et al. (2015) Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity, 42, 344-355. https://doi.org/10.1016/j.immuni.2015.01.010
|
[41]
|
Yang, J., Wei, H., Zhou, Y., et al. (2022) High-Fat Diet Promotes Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites. Gastroenterology, 162, 135-149.e2. https://doi.org/10.1053/j.gastro.2021.08.041
|
[42]
|
Rossen, N.G., Macdonald, J.K., De Vries, E.M., et al. (2015) Fecal Microbiota Transplantation as Novel Therapy in Gastroenterology: A Systematic Review. World Journal of Gastroenterology, 21, 5359-5371. https://doi.org/10.3748/wjg.v21.i17.5359
|
[43]
|
Kumar, A., Gautam, V., Sandhu, A., et al. (2023) Current and Emerging Therapeutic Approaches for Colorectal Cancer: A Comprehensive Review. World Journal of Gastrointestinal Surgery, 15, 495-519. https://doi.org/10.4240/wjgs.v15.i4.495
|
[44]
|
Mai, V., Colbert, L.H., Perkins, S.N., et al. (2007) Intestinal Microbiota: A Potential Diet-Responsive Prevention Target in ApcMin Mice. Molecular Carcinogenesis, 46, 42-48. https://doi.org/10.1002/mc.20233
|
[45]
|
Lee, S.Y., Lee, D.Y., Kang, J.H., et al. (2022) Relationship between Gut Microbiota and Colorectal Cancer: Probiotics as a Potential Strategy for Prevention. Food Research International, 156, Article ID: 111327. https://doi.org/10.1016/j.foodres.2022.111327
|